Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

METOCLOPRAMIDE 5 MG/5 ML SOLN

Metoclopramide
$0.1228per ML

Strength

5 mg/5mL

Manufacturer

ANI Pharmaceuticals, Inc.

NDC

62559019016

Classification

Generic

Dosage Form

SOLUTION

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

METOCLOPRAMIDE HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA071402

On Market Since

5/18/2015

Pharmacological Classes

Dopamine D2 Antagonists
Dopamine-2 Receptor Antagonist

Price History

1W

0.0%

1M

-3.1%

3M

-5.6%

6M

+0.3%

1Y

+206.8%

3Y

+204.8%

5Y

+221.9%

All

+962.2%

Generic Alternatives

1 alternative • Same active ingredient

METOCLOPRAMIDE 10 MG/2 ML VIAL
Generic
00703450204•Teva Parenteral Medicines, Inc.
$0.5198
+323% more

Related Drugs

Same classification

METOCLOPRAMIDE 5 MG/5 ML SOLN
Generic
62135052647•Chartwell RX LLC
$0.1228
per ML
METOCLOPRAMIDE 5 MG/5 ML SOLN
Generic
64950034416•Genus Lifesciences Inc.
$0.1228
per ML
METOCLOPRAMIDE 5 MG/5 ML SOLN
Generic
00121057616•PAI Holdings LLC
$0.1273
per ML
METOCLOPRAMIDE 10 MG/2 ML VIAL
Generic
00409341401•Hospira Inc.
$0.5198
per ML
METOCLOPRAMIDE 10 MG/2 ML VIAL
Generic
00409341411•Hospira Inc.
$0.5198
per ML
METOCLOPRAMIDE 10 MG/2 ML VIAL
Generic
00409525515•Hospira Inc.
$0.5198
per ML
METOCLOPRAMIDE 10 MG/2 ML VIAL
Generic
00409525525•Hospira Inc.
$0.5198
per ML
METOCLOPRAMIDE 10 MG/2 ML VIAL
Generic
23155024041•Heritage Pharmaceuticals Inc.
$0.5198
per ML
METOCLOPRAMIDE 10 MG/2 ML VIAL
Generic
83634077902•Avenacy Inc.
$0.5198
per ML

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy